SEALSQ (LAES) Q4 2025 earnings review
Top-Line Rebound Funded by Extreme Dilution
SEALSQ delivered an Accelerating top-line narrative in FY25, with revenue up 66% to $18.3M. However, this recovery masks a severe deterioration in operating leverage. Net loss expanded 61% to $34.2M, driven by massive increases in operating expenses. The company has essentially transformed into a capital-intensive investment vehicle, raising its cash pile to an astonishing $525M by March 2026 through aggressive equity offerings that nearly doubled shares outstanding. While the war chest removes liquidity risk and funds ambitious Quantum ecosystem investments, investors are paying a steep price in dilution while waiting for core Post-Quantum chips to hit volume production in late 2026.
🐂 Bull Case
With over $525M in cash and short-term investments following a March 2026 raise, SEALSQ has zero liquidity risk. It is fully funded to execute its $200M Quantum Fund strategy and complete M&A targets like Miraex.
The QS7001 secure chip has successfully passed critical Evaluation Assurance Level (EAL) 5+ hardware testing. With a pipeline exceeding $200M, volume production in late 2026 could rapidly scale revenue.
🐻 Bear Case
The massive cash balance came at the cost of current shareholders. Ordinary shares outstanding nearly doubled from 100M in FY24 to 191M in FY25, diluting equity prior to the massive $125M ATM raise in Q1 2026.
Total operating expenses reached $48.4M. General & Administrative expenses alone ($25.8M) were significantly larger than total company revenue ($18.3M), indicating a severe lack of near-term operating leverage.
⚖️ Verdict: 🔴
Bearish. While the company successfully navigated its 2024 revenue trough and is positioned well technologically, the operational burn rate is alarming. Buying revenue growth via M&A while relying on extreme, continuous equity dilution makes this a highly speculative holding until organic chip sales materialize.
Key Themes
QS7001 Certification Advances De-Risk Tech Roadmap
A crucial technology milestone was passed: the Quantum Shield QS7001—which embeds NIST-standardized Post-Quantum algorithms directly at the hardware level—passed critical fault injection and side-channel attack testing for CC EAL5+ certification. With evaluation kits in the hands of 10+ active prospects (including Lattice Semiconductor), this validates the core product viability ahead of late 2026 volume production.
IC'ALPS Acquisition Drives Near-Term Revenue
The August 2025 acquisition of ASIC-designer IC'ALPS is masking organic struggles but providing crucial top-line support. It contributed $3.5M for just five months in FY25 (nearly 20% of total revenue). A full year of consolidation in FY26 is the primary driver underpinning management's aggressive 50-100% revenue growth guidance.
Macro: Regulatory Tailwinds Force Upgrades
Management continues to cite global government mandates as the ultimate catalyst. Specifically, the US CNSA 2.0 migration timelines and sovereign semiconductor pushes are transforming post-quantum cryptography from an optional upgrade to a mandatory compliance requirement, driving the >$200M active pipeline.
Runaway Operating Expenses Contradict Growth Narrative
Management highlights 'clear commercial momentum' with 66% revenue growth, but the underlying data contradicts a scalable business model. General & Administrative expenses rocketed 138% YoY to $25.8M—meaning G&A alone eclipsed the entire $18.3M revenue base. While $11.2M of this was non-cash stock compensation, the cash burn remains highly disproportionate to top-line generation.
Severe Capital Structure Dilution
The company boasts of its >$525M balance sheet, but this was built entirely on the backs of shareholders. Shares outstanding surged from 100M at the end of 2024 to 191M at the end of 2025. A subsequent $125M 'At-The-Market' offering in March 2026 suggests dilution is Accelerating, severely limiting per-share value capture even if revenue hits targets.
Lengthy Sales Cycles and Certification Bottlenecks
Despite positive lab results for the QS7001, final formal Common Criteria and NIST FIPS 140-3 validations remain outside the company's control. The typical integration cycle spans 12-18 months. Any administrative delays in receiving these government stamps will push the 'late 2026' first-production revenue target into 2027.
Other KPIs
Reversing positively. Gross margin improved significantly from 34.0% in FY24 back toward historical norms, generating $8.6M in gross profit. This implies that the product mix, aided by IC'ALPS custom design work, is fundamentally profitable before getting wiped out by bloated operating expenses.
Accelerating. R&D spend jumped 150% from $5.0M in FY24. This is a necessary burn as the company pushes expensive evaluation milestones, fault injection testing, and silicon tape-outs for the Post-Quantum semiconductor roadmap.
Guidance
Accelerating. Represents over 100% YoY growth compared to Q1 2025. Driven by increased demand for Vault-IC secure elements and the full-quarter inclusion of IC'ALPS revenue.
Accelerating. Implies a range of $27.3M to $36.5M. The company explicitly states this will rely heavily on a full 12 months of IC'ALPS consolidation, PKI subscriptions, and initial pre-production QS7001 revenues late in the year.
Key Questions
M&A vs Organic Growth Split
Of the projected 50% to 100% revenue growth for FY26, exactly how much is modeled as organic growth from legacy products versus acquired revenue from IC'ALPS and the pending Miraex acquisition?
G&A Expense Normalization
General and Administrative expenses hit $25.8M in 2025. With the executive team now fully engaged, should investors view this as a permanent new run-rate, or were there one-time setup costs that will fall off in 2026?
Capital Allocation Framework
With an unprecedented $525M in cash and short-term investments, what is the ceiling for the internal SEALSQ Quantum Fund, and do you plan to halt further 'At-The-Market' equity dilution given the massive runway now secured?